Company Analysis
Sign in

Avita Medical, Inc. (RCEL)

Nasdaq: RCEL · Surgical & Medical Instruments & Apparatus · Valencia, CA · filing with the SEC since 2018
Full chart Alerts Compare
Grade5.3
◀ Past 6.6● Present 4.3▶ Future 5.3
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

4 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Avita Medical, Inc.’s names, not what it holds today.

Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 2 in 2024 and none in 2023
Applications published
20
2 of them in 2025
Names they are printed under
3
its own name, a subsidiary
By yearGrantedApplications published
'18'19'20'21'22'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology3
Chemical engineering1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
AVITA Medical, Inc. its own name
named as the applicant on its applications, in US. 2 more under the same name are not counted (printed in AU, printed in GB)
0 granted
13 published
AVITA Medical Americas, LLC a subsidiary
named as the applicant on its applications, in US
0 granted
7 published
AVITA Medical Americas, LLC a subsidiary
US, as the owner printed on each patent
4 granted
0 published
Names not counted (1)
AVITA Medical, Inc.
Most of its patents print GB; this name counts in US. 8 granted and 2 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Apr 22, 202512,281,298System for automated preparation of a regenerative epidermal suspension and related methods of useBiotechnologyAVITA Medical Americas, LLC
Apr 8, 202512,270,019Automated methodBiotechnologyAVITA Medical Americas, LLC
Dec 31, 202412,180,456Tissue healingBiotechnologyAVITA Medical Americas, LLC
May 21, 202411,987,787Devices, methods, and kits for preparing a cell suspensionChemical engineeringAVITA Medical Americas, LLC
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 13, 20252025/0346849AUTOMATED METHODBiotechnologyAVITA Medical Americas, LLC
Sep 18, 20252025/0290025SYSTEMS AND DEVICES FOR WOUND THERAPY AND RELATED METHODS OF USEBiotechnologyAVITA Medical Americas, LLC
Dec 5, 20242024/0400970DEVICES, METHODS, AND KITS FOR PREPARING A CELL SUSPENSIONChemical engineeringAVITA Medical Americas, LLC
Jun 27, 20242024/0209307SYSTEM FOR AUTOMATED PREPARATION OF A REGENERATIVE EPIDERMAL SUSPENSION AND RELATED METHODS OF USEBiotechnologyAVITA Medical Americas, LLC · patent 12,281,298 granted from it
Jun 27, 20242024/0209299CARTRIDGE FOR TISSUE TREATMENTBiotechnologyAVITA Medical Americas, LLC
Jun 27, 20242024/0209296TISSUE HEALINGBiotechnologyAVITA Medical Americas, LLC · patent 12,180,456 granted from it
Jun 27, 20242024/0207841AUTOMATED METHODBiotechnologyAVITA Medical Americas, LLC · patent 12,270,019 granted from it
Nov 3, 20222022/0349873CELL SUSPENSION COMPOSITION WITH THERAPEUTIC POTENTIAL AND RELATED METHODS AND SYSTEMS FOR IDENTIFYING SAMEMeasurementAVITA Medical, Inc.
Nov 3, 20222022/0347352CELL SUSPENSION COMPOSITION WITH THERAPEUTIC POTENTIAL AND RELATED METHODS AND SYSTEMS FOR IDENTIFYING SAMEMeasurementAVITA Medical, Inc.
Oct 27, 20222022/0339254REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIESPharmaceuticalsAVITA Medical, Inc.
What it applied for, 2024 to 2025: Biotechnology 6 · Chemical engineering 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton RCEL · research, not advice